litigation

News

Purdue and Sacklers agree new $7.4bn opioid settlement

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of opioid-related lawsuits.

News

Sage sues Biogen after unsolicited takeover bid

Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal.

News

Insulin pump firm Insulet wins $452m in trade secrets clash

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

News

Novartis bid to block generic Entresto in US suffers setback

An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.

News

BMS files legal challenge to HHS' 340B rebate decision

Bristol-Myers Squibb has become the latest pharma in the US to file a legal challenge to a block on a 340B drug rebate model opposed by HRSA.

News

Pharmas ask appeals court to reconsider IRA lawsuits

The pharma industry's challenge to Medicare drug price negotiation powers continues to rumble on, with three drugmakers asking a US appeals court to revive their lawsuits.

Purdue and Sacklers agree new $7.4bn opioid settlement

Sage sues Biogen after unsolicited takeover bid

Insulin pump firm Insulet wins $452m in trade secrets clash

Novartis bid to block generic Entresto in US suffers setback

BMS files legal challenge to HHS' 340B rebate decision

Pharmas ask appeals court to reconsider IRA lawsuits

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

litigation

Editor's Picks